Cityshrimp@lemmy.worldMEnglish · 1 year agoGeneral Chat pinmessage-squaremessage-square0fedilinkarrow-up11arrow-down10
arrow-up11arrow-down1message-squareGeneral Chat pinCityshrimp@lemmy.worldMEnglish · 1 year agomessage-square0fedilink
Cityshrimp@lemmy.worldMEnglish · edit-21 year agoCheat Sheetplus-squarepinmessage-squaremessage-square0fedilinkarrow-up11arrow-down10
arrow-up11arrow-down1message-squareCheat Sheetplus-squarepinCityshrimp@lemmy.worldMEnglish · edit-21 year agomessage-square0fedilink
CityShrimp@lemmy.sdf.orgEnglish · 1 year agoBiora Therapeutics Announces New Patents Covering its BioJet™ Systemic Oral Delivery Platforminvestors.bioratherapeutics.comexternal-linkmessage-square0fedilinkarrow-up12arrow-down10
arrow-up12arrow-down1external-linkBiora Therapeutics Announces New Patents Covering its BioJet™ Systemic Oral Delivery Platforminvestors.bioratherapeutics.comCityShrimp@lemmy.sdf.orgEnglish · 1 year agomessage-square0fedilink
CityShrimp@lemmy.sdf.orgEnglish · 1 year agoBiora Therapeutics to Participate in Canaccord Genuity 43rd Annual Growth Conferenceinvestors.bioratherapeutics.comexternal-linkmessage-square0fedilinkarrow-up13arrow-down10
arrow-up13arrow-down1external-linkBiora Therapeutics to Participate in Canaccord Genuity 43rd Annual Growth Conferenceinvestors.bioratherapeutics.comCityShrimp@lemmy.sdf.orgEnglish · 1 year agomessage-square0fedilink
CityShrimp@lemmy.sdf.orgEnglish · 1 year agoBiora Therapeutics Announces Clinical Device Performance Study Results for its NaviCap™ Targeted Oral Delivery Platforminvestors.bioratherapeutics.comexternal-linkmessage-square0fedilinkarrow-up11arrow-down10
arrow-up11arrow-down1external-linkBiora Therapeutics Announces Clinical Device Performance Study Results for its NaviCap™ Targeted Oral Delivery Platforminvestors.bioratherapeutics.comCityShrimp@lemmy.sdf.orgEnglish · 1 year agomessage-square0fedilink
CityShrimp@lemmy.sdf.orgEnglish · 1 year agoJuly 2023 Corporate Presentationinvestors.bioratherapeutics.comexternal-linkmessage-square0fedilinkarrow-up12arrow-down10cross-posted to: biora@lemmy.world
arrow-up12arrow-down1external-linkJuly 2023 Corporate Presentationinvestors.bioratherapeutics.comCityShrimp@lemmy.sdf.orgEnglish · 1 year agomessage-square0fedilinkcross-posted to: biora@lemmy.world
Cityshrimp@lemmy.worldMEnglish · 1 year agoBiora Therapeutics Continues to Monetize Legacy Diagnostics Assetsplus-squareinvestors.bioratherapeutics.comexternal-linkmessage-square0fedilinkarrow-up11arrow-down10
arrow-up11arrow-down1external-linkBiora Therapeutics Continues to Monetize Legacy Diagnostics Assetsplus-squareinvestors.bioratherapeutics.comCityshrimp@lemmy.worldMEnglish · 1 year agomessage-square0fedilink
CityShrimp@lemmy.sdf.orgEnglish · 1 year agoTesting post from a different instance message-squaremessage-square0fedilinkarrow-up11arrow-down10
arrow-up11arrow-down1message-squareTesting post from a different instance CityShrimp@lemmy.sdf.orgEnglish · 1 year agomessage-square0fedilink
Cityshrimp@lemmy.worldMEnglish · 1 year agoBiora Therapeutics Announces New Patents for its NaviCap™ Targeted Oral Delivery Platform investors.bioratherapeutics.comexternal-linkmessage-square0fedilinkarrow-up11arrow-down10
arrow-up11arrow-down1external-linkBiora Therapeutics Announces New Patents for its NaviCap™ Targeted Oral Delivery Platform investors.bioratherapeutics.comCityshrimp@lemmy.worldMEnglish · 1 year agomessage-square0fedilink
